D
Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
D
Sell
2/24/2025Upgraded
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 2/24/2025 due to an increase in the volatility index and total return index.
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 2/24/2025 due to an increase in the volatility index and total return index.
E
Sell
2/6/2025Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 2/6/2025 due to a decline in the volatility index.
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 2/6/2025 due to a decline in the volatility index.
D
Sell
1/22/2025Upgraded
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 1/22/2025 due to an increase in the volatility index and total return index.
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 1/22/2025 due to an increase in the volatility index and total return index.
E
Sell
1/7/2025Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 1/7/2025 due to a decline in the volatility index and solvency index. The quick ratio declined from 10.42 to 9.83.
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 1/7/2025 due to a decline in the volatility index and solvency index. The quick ratio declined from 10.42 to 9.83.
D
Sell
10/2/2024Upgraded
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 10/2/2024 due to an increase in the volatility index.
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 10/2/2024 due to an increase in the volatility index.
E
Sell
9/17/2024Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 9/17/2024 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.0093 to -$0.0244, and total revenue declined 2.09% from $6.26M to $6.13M.
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 9/17/2024 due to a decline in the growth index and volatility index. Earnings per share declined from -$0.0093 to -$0.0244, and total revenue declined 2.09% from $6.26M to $6.13M.
D
Sell
6/3/2024Upgraded
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 6/3/2024 due to an increase in the total return index, valuation index and volatility index.
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 6/3/2024 due to an increase in the total return index, valuation index and volatility index.
E
Sell
2/15/2024Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 2/15/2024 due to a decline in the total return index, volatility index and growth index.
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 2/15/2024 due to a decline in the total return index, volatility index and growth index.
D
Sell
1/30/2024Upgraded
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 1/30/2024 due to an increase in the valuation index.
Zomedica Corp. (ZOM) was upgraded to D- from E+ on 1/30/2024 due to an increase in the valuation index.
E
Sell
1/4/2024Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 1/4/2024 due to a decline in the volatility index and solvency index. The quick ratio declined from 18.37 to 16.12.
Zomedica Corp. (ZOM) was downgraded to E+ from D- on 1/4/2024 due to a decline in the volatility index and solvency index. The quick ratio declined from 18.37 to 16.12.
D
Sell
3/14/2023Downgrade
Zomedica Corp. (ZOMDF) was downgraded to D- from D on 03/14/2023.
Zomedica Corp. (ZOMDF) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Zomedica Corp. (ZOM) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, volatility index and valuation index.
Zomedica Corp. (ZOM) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index, volatility index and valuation index.
D
Sell
2/8/2023Downgrade
Zomedica Corp. (ZOM) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index and valuation index.
Zomedica Corp. (ZOM) was downgraded to D- from D on 2/8/2023 due to a noticeable decline in the total return index and valuation index.
D
Sell
5/31/2022Upgraded
Zomedica Corp. (ZOMDF) was upgraded to D from D- on 05/31/2022.
Zomedica Corp. (ZOMDF) was upgraded to D from D- on 05/31/2022.
D
Sell
5/13/2022Downgrade
Zomedica Corp. (ZOM) was downgraded to D- from D on 5/13/2022 due to a decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0034 to -$0.004, and total revenue declined 8.08% from $4.08M to $3.75M.
Zomedica Corp. (ZOM) was downgraded to D- from D on 5/13/2022 due to a decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0034 to -$0.004, and total revenue declined 8.08% from $4.08M to $3.75M.
D
Sell
5/5/2022Upgraded
Zomedica Corp. (ZOM) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index, growth index and valuation index.
Zomedica Corp. (ZOM) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index, growth index and valuation index.
D
Sell
4/20/2022Downgrade
Zomedica Corp. (ZOM) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index.
Zomedica Corp. (ZOM) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index.
D
Sell
11/9/2021Upgraded
Zomedica Corp. (ZOM) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Zomedica Corp. (ZOM) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Zomedica Corp. (ZOM) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
Zomedica Corp. (ZOM) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
12/23/2020Upgraded
Zomedica Corp. (ZOM) was upgraded to D from D- on 12/23/2020 due to an increase in the total return index and volatility index.
Zomedica Corp. (ZOM) was upgraded to D from D- on 12/23/2020 due to an increase in the total return index and volatility index.
D
Sell
12/4/2020Downgrade
Zomedica Corp. (ZOM) was downgraded to D- from D on 12/4/2020 due to a decline in the volatility index and valuation index.
Zomedica Corp. (ZOM) was downgraded to D- from D on 12/4/2020 due to a decline in the volatility index and valuation index.
D
Sell
11/18/2020Upgraded
Zomedica Corp. (ZOM) was upgraded to D from D- on 11/18/2020 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 15.25 to 25.2, earnings per share increased from -$0.0247 to -$0.01, and EBIT increased 5.7% from -$5.3M to -$5M.
Zomedica Corp. (ZOM) was upgraded to D from D- on 11/18/2020 due to a noticeable increase in the growth index, solvency index and valuation index. The quick ratio increased from 15.25 to 25.2, earnings per share increased from -$0.0247 to -$0.01, and EBIT increased 5.7% from -$5.3M to -$5M.
D
Sell
8/12/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 8/12/2020 due to a noticeable decline in the growth index, valuation index and volatility index. Operating cash flow declined 163.24% from -$2.17M to -$5.72M, EBIT declined 127.23% from -$2.33M to -$5.3M, and earnings per share declined from -$0.0207 to -$0.0247.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 8/12/2020 due to a noticeable decline in the growth index, valuation index and volatility index. Operating cash flow declined 163.24% from -$2.17M to -$5.72M, EBIT declined 127.23% from -$2.33M to -$5.3M, and earnings per share declined from -$0.0207 to -$0.0247.
D
Sell
7/27/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 7/27/2020 due to an increase in the volatility index and total return index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 7/27/2020 due to an increase in the volatility index and total return index.
D
Sell
7/10/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 7/10/2020 due to a decline in the volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 7/10/2020 due to a decline in the volatility index.
D
Sell
6/19/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 6/19/2020 due to an increase in the volatility index and total return index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 6/19/2020 due to an increase in the volatility index and total return index.
D
Sell
6/4/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 6/4/2020 due to a decline in the volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 6/4/2020 due to a decline in the volatility index.
D
Sell
5/14/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 5/14/2020 due to an increase in the volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 5/14/2020 due to an increase in the volatility index.
D
Sell
5/13/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 5/13/2020 due to a major increase in the growth index. Earnings per share increased from -$0.0304 to -$0.02, and EBIT increased 18.33% from -$2.86M to -$2.33M.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 5/13/2020 due to a major increase in the growth index. Earnings per share increased from -$0.0304 to -$0.02, and EBIT increased 18.33% from -$2.86M to -$2.33M.
E
Sell
4/2/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 4/2/2020 due to a decline in the volatility index and total return index.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 4/2/2020 due to a decline in the volatility index and total return index.
D
Sell
3/18/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 3/18/2020 due to an increase in the volatility index and solvency index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 3/18/2020 due to an increase in the volatility index and solvency index.
E
Sell
2/28/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/28/2020 due to a decline in the volatility index, efficiency index and total return index. Total capital declined 58.37% from $5.03M to $2.1M, and net income declined 0.4% from -$2.85M to -$2.86M.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/28/2020 due to a decline in the volatility index, efficiency index and total return index. Total capital declined 58.37% from $5.03M to $2.1M, and net income declined 0.4% from -$2.85M to -$2.86M.
D
Sell
2/25/2020Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 2/25/2020 due to an increase in the volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 2/25/2020 due to an increase in the volatility index.
E
Sell
2/10/2020Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/10/2020 due to a decline in the growth index and efficiency index. Earnings per share declined from -$0.0223 to -$0.03, total capital declined 34.48% from $7.68M to $5.03M, and EBIT declined 18.96% from -$2.39M to -$2.84M.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/10/2020 due to a decline in the growth index and efficiency index. Earnings per share declined from -$0.0223 to -$0.03, total capital declined 34.48% from $7.68M to $5.03M, and EBIT declined 18.96% from -$2.39M to -$2.84M.
D
Sell
9/18/2019Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 9/18/2019 due to an increase in the total return index, solvency index and volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D- from E+ on 9/18/2019 due to an increase in the total return index, solvency index and volatility index.
E
Sell
8/13/2019Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D on 8/13/2019 due to a significant decline in the efficiency index, total return index and volatility index.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D on 8/13/2019 due to a significant decline in the efficiency index, total return index and volatility index.
D
Sell
5/15/2019Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from E+ on 5/15/2019 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 22.44% from -$3.33M to -$2.58M.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from E+ on 5/15/2019 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 22.44% from -$3.33M to -$2.58M.
E
Sell
2/27/2019Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/27/2019 due to a large decline in the volatility index, growth index and total return index. EBIT declined 356.19% from -$1.85M to -$8.42M, and earnings per share declined from -$0.0202 to -$0.0883.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to E+ from D- on 2/27/2019 due to a large decline in the volatility index, growth index and total return index. EBIT declined 356.19% from -$1.85M to -$8.42M, and earnings per share declined from -$0.0202 to -$0.0883.
D
Sell
11/26/2018Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 11/26/2018 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 2.57 to 0.44.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 11/26/2018 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 2.57 to 0.44.
D
Sell
10/25/2018Upgraded
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 10/25/2018 due to an increase in the volatility index and valuation index.
Zomedica Pharmaceuticals Corp. (ZOM) was upgraded to D from D- on 10/25/2018 due to an increase in the volatility index and valuation index.
D
Sell
9/19/2018Downgrade
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 9/19/2018 due to a noticeable decline in the volatility index, growth index and total return index. EBIT declined 91.16% from -$2.17M to -$4.15M, earnings per share declined from -$0.024 to -$0.0448, and operating cash flow declined 60.47% from -$1.71M to -$2.74M.
Zomedica Pharmaceuticals Corp. (ZOM) was downgraded to D- from D on 9/19/2018 due to a noticeable decline in the volatility index, growth index and total return index. EBIT declined 91.16% from -$2.17M to -$4.15M, earnings per share declined from -$0.024 to -$0.0448, and operating cash flow declined 60.47% from -$1.71M to -$2.74M.
D
Sell
8/1/2017Upgraded
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to D from D- on 8/1/2017 due to an increase in the total return index, growth index and efficiency index. Earnings per share increased from -$0.039 to -$0.0217, net income increased 38.38% from -$2.97M to -$1.83M, and EBIT increased 37.86% from -$2.97M to -$1.85M.
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to D from D- on 8/1/2017 due to an increase in the total return index, growth index and efficiency index. Earnings per share increased from -$0.039 to -$0.0217, net income increased 38.38% from -$2.97M to -$1.83M, and EBIT increased 37.86% from -$2.97M to -$1.85M.
D
Sell
4/3/2017Upgraded
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to D- from E+ on 4/3/2017 due to an increase in the total return index, valuation index and growth index. Operating cash flow increased 8.63% from -$1.62M to -$1.48M.
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to D- from E+ on 4/3/2017 due to an increase in the total return index, valuation index and growth index. Operating cash flow increased 8.63% from -$1.62M to -$1.48M.
E
Sell
1/3/2017Upgraded
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to E+ from E on 1/3/2017 due to a major increase in the total return index, efficiency index and valuation index. Total capital increased 134.81% from $2.11M to $4.94M, and net income increased 2.1% from -$1.06M to -$1.04M.
Zomedica Pharmaceuticals Corp. (ZOMHF) was upgraded to E+ from E on 1/3/2017 due to a major increase in the total return index, efficiency index and valuation index. Total capital increased 134.81% from $2.11M to $4.94M, and net income increased 2.1% from -$1.06M to -$1.04M.
E
Sell
10/21/2016None
Zomedica Corp. (ZOMDF) was downgraded to E from U on 10/21/2016.
Zomedica Corp. (ZOMDF) was downgraded to E from U on 10/21/2016.
OTC PK
03/14/2025 3:59PM Eastern
Quotes delayed
